ARTICLE | Financial News
CMAB raises $38M series A
January 5, 2018 9:18 PM UTC
CMAB Biopharma Inc. (Suzhou, China) raised $38 million on Jan. 2 in a series A round led by C-Bridge Capital and BioBay. I-Bridge Capital and Qianhai FoF fund also participated.
The contract development and manufacturing organization follows global GMP standards and has capabilities in biologics development, formulation and manufacturing. CMAB will initially focus on generating preclinical and Phase I/II biologics for companies worldwide...
BCIQ Company Profiles